These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9476743)

  • 1. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.
    Scott LV; Dinan TG
    J Affect Disord; 1998 Jan; 47(1-3):49-54. PubMed ID: 9476743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK; Taylor NF; Peters TJ; Wessely S; Cleare AJ
    Psychosom Med; 2006; 68(4):578-82. PubMed ID: 16868267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK; Peters TJ; Taylor NF; Wood PJ; Wessely S; Cleare AJ
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading.
    Maes M; Vandevelde R; Suy E
    J Affect Disord; 1989; 17(2):173-82. PubMed ID: 2549110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
    J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers.
    Uhde TW; Tancer ME; Gelernter CS; Vittone BJ
    J Affect Disord; 1994 Mar; 30(3):155-61. PubMed ID: 8006242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.
    Papadopoulos AS; Cleare AJ
    Nat Rev Endocrinol; 2011 Sep; 8(1):22-32. PubMed ID: 21946893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.
    Maes M; Minner B; Suy E; Vandervorst C; Raus J
    J Neural Transm Gen Sect; 1991; 85(3):195-210. PubMed ID: 1930881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary-free cortisol in depressed patients and controls: relationship to urinary indices of noradrenergic function.
    Roy A; Linnoila M; Karoum F; Pickar D
    Psychol Med; 1988 Feb; 18(1):93-8. PubMed ID: 3363046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK; Cleare AJ; Wessely S; Wood PJ; Taylor NF
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 1microg short Synacthen test in chronic fatigue syndrome.
    Hudson M; Cleare AJ
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):625-30. PubMed ID: 10594524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL; Rutten JM; Uiterwaal CS; Bleijenberg G; Kimpen JL; Putte EM
    Psychoneuroendocrinology; 2014 Apr; 42():199-206. PubMed ID: 24636516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Dinan TG; Majeed T; Lavelle E; Scott LV; Berti C; Behan P
    Psychoneuroendocrinology; 1997 May; 22(4):261-7. PubMed ID: 9226729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
    Scott LV; Medbak S; Dinan TG
    Biol Psychiatry; 1999 Jun; 45(11):1447-54. PubMed ID: 10356627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.